Dr. Carson Andrew Mclain, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Ne 10th St, Blanchard, OK 73010 Phone: 405-485-9311 Fax: 405-485-9312 |
Rochelle Elaine Landreth, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Ne 10th St, Blanchard, OK 73010 Phone: 405-485-9311 Fax: 405-485-9312 |
Dr. Keaton Dane Hasty, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1203 N Council Rd, Blanchard, OK 73010 Phone: 405-485-2112 Fax: 405-485-8661 |
Lisa Standridge Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1203 N Council Rd, Blanchard, OK 73010 Phone: 405-485-2112 Fax: 405-485-8661 |
Michael E Meek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Ne 10th St, Blanchard, OK 73010 Phone: 405-485-9311 Fax: 405-485-9312 |
News Archive
Anergis, a company focusing on proprietary allergy vaccines, today reported immunology data from the Phase IIb study of its lead compound AllerT.
The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, encourages men to speak out to preserve prostate cancer screenings.
When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.
Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, announced today that it has acquired Medical Specialties Distributors, LLC (MSD). Headquartered in Stoughton, Massachusetts, MSD is the nation's leading provider of infusion products, supplies, biomedical services and technology solutions to the growing home infusion therapy market. The acquisition expands Water Street's current group of health care companies to 12.
Individuals have a right to participate in risky research trials, which might harm their health or even kill them, and institutional review boards (known as research ethics committees in the UK) – which are responsible for deciding whether a particular research trial can take place in a given institution – are potentially impeding the progress of research by rejecting such studies on ethical grounds, according to a Viewpoint published in The Lancet today [Wednesday 18 September].
› Verified 9 days ago